Tigofast-120 film-coated tablets 120 mg blister No. 30

Tigofast-120 tablets are used for the symptomatic treatment of seasonal allergic rhinitis in adults and children over 12 years of age.

Composition

The active substance is fexofenadine hydrochloride (one film-coated tablet contains 120 mg of fexofenadine hydrochloride).

Excipients: microcrystalline cellulose, corn starch, sodium starch glycolate (type A), colloidal anhydrous silicon dioxide, Insta Coat White film coating (ethylcellulose, hydroxypropylmethylcellulose, titanium dioxide (E 171)), talc.

Contraindication

Method of application

Adults and children over 12 years of age are prescribed the drug for seasonal allergic rhinitis - 120 mg 1 time per day. Take orally before meals, with water. The duration of treatment is determined individually, depending on the severity of the disease.

Application features

Pregnant women

Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary, when the expected benefit to the mother outweighs the potential risk to the fetus.

Since fexofenadine passes into breast milk, the drug should not be used during breastfeeding.

Children

In this dosage, the drug should not be used in children under 12 years of age.

Drivers

Based on the pharmacodynamic profile and known side effects, it can be concluded that taking this drug does not affect the ability to drive vehicles and perform work requiring concentration of attention. When conducting objective studies, it was found that the drug does not have a significant effect on the functions of the central nervous system (CNS). However, it is recommended to assess the individual response to the drug before starting to drive vehicles or perform work requiring concentration of attention.

Overdose

Most reports of overdose with fexofenadine hydrochloride are not informative enough. For example, dizziness, drowsiness, and dry mouth have been reported.

In case of overdose, the usual measures should be taken to remove unabsorbed active substances. Symptomatic and supportive therapy is recommended. Removal of fexofenadine hydrochloride from the blood by hemodialysis is ineffective.

Side effects

From the nervous system: headache, drowsiness, dizziness.

Gastrointestinal: nausea, diarrhea, epigastric cramps.

General disorders and administration site conditions: feeling of increased fatigue.

Immune system: hypersensitivity reactions, including angioedema, chest tightness, shortness of breath, facial flushing and systemic anaphylactic reactions, dyspnea, flushing.

On the part of the psyche: insomnia, increased irritability and sleep disturbances or unusual dreams (paroniria).

Cardiac: tachycardia, palpitations.

Skin and subcutaneous tissue disorders: rash, exanthema, urticaria, itching.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C, out of the reach of children.

Shelf life - 2 years.